SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Zhao Hong-Xia, Sun Wan-Jun, Li Jie, Hu Hai-Lan, Ai Hui-Sheng, Programmed Haploidentical Hematopoietic Stem Cell Infusion Combined with Systemic Chemotherapy Improves the Outcomes of Patients with Refractory or Relapsed Lymphoma, Leukemia & Lymphoma, 2014, 1

    CrossRef

  2. 2
    Ephraim J. Fuchs, Transplantation tolerance: from theory to clinic, Immunological Reviews, 2014, 258, 1
  3. 3
    Loren Fast, John Reagan, Peter Quesenberry, Cellular Immunotherapy: Using Alloreactivity to Induce Anti-Leukemic Responses without Prolonged Persistence of Donor Cells, Medical Sciences, 2013, 1, 1, 37

    CrossRef

  4. 4
    P T Jindra, S Tripathi, C Tian, J Iacomini, J Bagley, Tolerance to MHC class II disparate allografts through genetic modification of bone marrow, Gene Therapy, 2013, 20, 5, 478

    CrossRef

  5. 5
    Hao Wei Li, Megan Sykes, Emerging concepts in haematopoietic cell transplantation, Nature Reviews Immunology, 2012, 12, 6, 403

    CrossRef

  6. 6
    Amir A. Toor, Roy T. Sabo, Harold M. Chung, Catherine Roberts, Rose H. Manjili, Shiyu Song, David C. Williams, Wendy Edmiston, Mandy L. Gatesman, Richard W. Edwards, Andrea Ferreira-Gonzalez, William B. Clark, Michael C. Neale, John M. McCarty, Masoud H. Manjili, Favorable Outcomes in Patients with High Donor-Derived T Cell Count after In Vivo T Cell–Depleted Reduced-Intensity Allogeneic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2012, 18, 5, 794

    CrossRef

  7. 7
    John T. Reynolds, John M. Watkins, Tarek A. Dufan, Shrikant S. Kubsad, Irradiation of Donor Mononuclear Cells for Treatment of Chemorefractory Metastatic Solid Cancers: A Community-Based Immune Transplant Pilot Study, Cancer Research and Treatment, 2012, 44, 2, 133

    CrossRef

  8. 8
    John L. Reagan, Loren D. Fast, Eric S. Winer, Howard Safran, James N. Butera, Peter J. Quesenberry, Nonengraftment Haploidentical Cellular Therapy for Hematologic Malignancies, Advances in Hematology, 2012, 2012, 1

    CrossRef

  9. 9
    Yi-Bin Chen, Julie Aldridge, Haesook T. Kim, Karen K. Ballen, Corey Cutler, Grace Kao, Deborah Liney, Greg Bourdeau, Edwin P. Alyea, Philippe Armand, John Koreth, Jerome Ritz, Thomas R. Spitzer, Robert J. Soiffer, Joseph H. Antin, Vincent T. Ho, Reduced-Intensity Conditioning Stem Cell Transplantation: Comparison of Double Umbilical Cord Blood and Unrelated Donor Grafts, Biology of Blood and Marrow Transplantation, 2012, 18, 5, 805

    CrossRef

  10. 10
    S. Mackinnon, R. Chakraverty, Families get mobilized to treat AML, Blood, 2011, 117, 3, 746

    CrossRef

  11. 11
    Thomas R. Spitzer, Megan Sykes, Nina Tolkoff-Rubin, Tatsuo Kawai, Steven L. McAfee, Bimalangshu R. Dey, Karen Ballen, Francis Delmonico, Susan Saidman, David H. Sachs, A. Benedict Cosimi, Long-Term Follow-Up of Recipients of Combined Human Leukocyte Antigen-Matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With End-Stage Renal Disease, Transplantation, 2011, 91, 6, 672

    CrossRef

  12. 12
    Samuel Strober, Thomas R. Spitzer, Robert Lowsky, Megan Sykes, Translational studies in hematopoietic cell transplantation: Treatment of hematologic malignancies as a stepping stone to tolerance induction, Seminars in Immunology, 2011, 23, 4, 273

    CrossRef

  13. 13
    Ashley T. Munchel, Yvette L. Kasamon, Ephraim J. Fuchs, Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide, Best Practice & Research Clinical Haematology, 2011, 24, 3, 359

    CrossRef

  14. 14
    E Daguindau, B Lioure, A Buzyn, M Robin, C Faucher, M Kuentz, P Tiberghien, E Deconinck, Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment, Bone Marrow Transplantation, 2010, 45, 1, 177

    CrossRef

  15. 15
    Leo Luznik, Ephraim J. Fuchs, High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation, Immunologic Research, 2010, 47, 1-3, 65

    CrossRef

  16. 16
    Chaorui Tian, Xueli Yuan, Peter T. Jindra, Jessamyn Bagley, Mohamed H. Sayegh, John Iacomini, Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen, Clinical Immunology, 2010, 136, 2, 174

    CrossRef

  17. 17
    Toshiki I. Saito, Joji Fujisaki, Alicia L. Carlson, Charles P. Lin, Megan Sykes, Persistence of donor-derived protein in host myeloid cells after induced rejection of engrafted allogeneic bone marrow cells, Experimental Hematology, 2010, 38, 4, 333

    CrossRef

  18. You have open access to this content18
    Masumitsu Hamaguchi, Masatoshi Eto, Yoriyuki Kamiryo, Ario Takeuchi, Masahiko Harano, Katsunori Tatsugami, Takanori Teshima, Mamoru Harada, Yasunobu Yoshikai, Seiji Naito, Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide-using non-myeloablative allogeneic hematopoietic cell transplantation, Cancer Science, 2009, 100, 1
  19. 19
    Rachael Hough, Nicola Cooper, Paul Veys, Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available?, British Journal of Haematology, 2009, 147, 5
  20. 20
    Gerald A. Colvin, David Berz, Muthalagu Ramanathan, Eric S. Winer, Loren Fast, Gerald J. Elfenbein, Peter J. Quesenberry, Nonengraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism, Biology of Blood and Marrow Transplantation, 2009, 15, 4, 421

    CrossRef

  21. 21
    Daniel J. Medina, Mecide Gharibo, Philip Savage, Alan Cohler, Mercy Kuriyan, Binaifer Balsara, Monika Anand, Dale Schaar, Tracy Krimmel, Kara Saggiomo, Jacqueline Manago, Lois Talty, Liesel Dudek, Stephanie Grospe, Arnold Rubin, Roger K. Strair, A Pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies, Leukemia Research, 2008, 32, 12, 1842

    CrossRef

  22. 22
    Y-B Chen, T R Spitzer, Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors, Leukemia, 2008, 22, 1, 31

    CrossRef

  23. 23
    A Toor, T Rodriguez, M Bauml, H Mathews, S Shanti, D Senitzer, A Kini, J Norton, M Parthasarathy, N Mohideen, C Petrowsky, B Bonilla, S Smith, P Stiff, Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT, Bone Marrow Transplantation, 2008, 42, 11, 723

    CrossRef

  24. 24
    Chaorui Tian, Xueli Yuan, Jessamyn Bagley, Bruce R. Blazar, Mohamed H. Sayegh, John Iacomini, Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells, Clinical Immunology, 2008, 127, 2, 130

    CrossRef

  25. 25
    Peter Lang, Ingo Mueller, Johann Greil, Peter Bader, Michael Schumm, Matthias Pfeiffer, Walter Hoelle, Thomas Klingebiel, Frank Heinzelmann, Claus Belka, Paul G. Schlegel, Bernhard Kremens, Wilhelm Woessmann, Rupert Handgretinger, Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients, Blood Cells, Molecules, and Diseases, 2008, 40, 1, 33

    CrossRef

  26. 26
    Heather J. Symons, Moshe Y. Levy, Jie Wang, Xiaotao Zhou, Gang Zhou, Sarah E. Cohen, Leo Luznik, Hyam I. Levitsky, Ephraim J. Fuchs, The Allogeneic Effect Revisited: Exogenous Help for Endogenous, Tumor-Specific T Cells, Biology of Blood and Marrow Transplantation, 2008, 14, 5, 499

    CrossRef

  27. 27
    S Fevery, A D Billiau, B Sprangers, O Rutgeerts, C Lenaerts, J Goebels, W Landuyt, A Kasran, L Boon, X Sagaert, C De Wolf-Peeters, M Waer, P Vandenberghe, CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease, Leukemia, 2007, 21, 7, 1451

    CrossRef

  28. 28
    Ben Sprangers, Bart Van Wijmeersch, Sabine Fevery, Mark Waer, An D Billiau, Experimental and clinical approaches for optimization of the graft-versus-leukemia effect, Nature Clinical Practice Oncology, 2007, 4, 7, 404

    CrossRef

  29. 29
    Toshiki I. Saito, Marie T. Rubio, Megan Sykes, Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation, Experimental Hematology, 2006, 34, 9, 1270

    CrossRef

  30. 30
    Y. Fudaba, T. R. Spitzer, J. Shaffer, T. Kawai, T. Fehr, F. Delmonico, F. Preffer, N. Tolkoff-Rubin, B. R. Dey, S. L. Saidman, A. Kraus, T. Bonnefoix, S. McAfee, K. Power, K. Kattleman, R. B. Colvin, D. H. Sachs, A. B. Cosimi, M. Sykes, Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses, American Journal of Transplantation, 2006, 6, 9
  31. 31
    C. Tian, J. Bagley, J. Iacomini, Persistence of Antigen Is Required to Maintain Transplantation Tolerance Induced by Genetic Modification of Bone Marrow Stem Cells, American Journal of Transplantation, 2006, 6, 9
  32. 32
    Marie-Therese Rubio, Guiling Zhao, Jennifer Buchli, Meredith Chittenden, Megan Sykes, Role of indirect allo- and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions (RLI) in mixed chimeras prepared with nonmyeloablative conditioning, Clinical Immunology, 2006, 120, 1, 33

    CrossRef

  33. 33
    Karen K. Ballen, Gerald Colvin, Bimalangshu R. Dey, David Porter, Peter Westervelt, Thomas R. Spitzer, Peter J. Quesenberry, Cellular immune therapy for refractory cancers: novel therapeutic strategies, Experimental Hematology, 2005, 33, 12, 1427

    CrossRef